Evidence supporting the use of: Phaeophyceae (unspecified)
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Phaeophyceae, commonly known as brown seaweeds (including genera such as Laminaria, Fucus, and Undaria), contains bioactive compounds such as alginates, fucoidans, laminarin, and significant amounts of minerals, especially calcium and magnesium. Scientific interest in Phaeophyceae for the support or treatment of osteoporosis is based primarily on these constituents. Several in vitro and animal studies have shown that extracts from brown algae can improve bone mineral density and stimulate bone formation, likely due to their content of calcium, magnesium, and bioactive polysaccharides like fucoidan. Fucoidan, in particular, has demonstrated osteogenic and anti-resorptive effects in laboratory settings and in animal models, possibly by modulating osteoblast and osteoclast activity, reducing inflammation, and affecting signaling pathways involved in bone metabolism.

However, clinical evidence in humans is limited, with very few studies directly testing brown algae supplements or extracts for the prevention or treatment of osteoporosis. Most available data come from preclinical research, and while the results are promising, they do not yet constitute robust or high-quality clinical evidence. Thus, the use of Phaeophyceae for osteoporosis is scientifically plausible and supported by early-stage research, but more well-designed human trials are necessary before it can be recommended as an evidence-based intervention.

More about Phaeophyceae (unspecified)
More about Osteoporosis

Products containing Phaeophyceae (unspecified)

We currently have no products on Vitabase that contain this ingredient.